Quick Answer
Caris Life Sciences, Inc. reported Long Term Debt of $378.82 million for the year ending 2025.
- Caris Life Sciences, Inc. showed an increase of +18.6% in Long Term Debt from 2024 to 2025.
- This data is from Caris Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2025: $373.61 million | Q3 2025: $376.30 million.
- Historical annual values: Fiscal year 2025: $378.82 million | Fiscal year 2024: $319.44 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: